Inflammation is artery-wall activity
In this atlas, inflammation means immune-cell involvement, chemical signalling, and vessel-wall irritation. It is not a vague warning label.
Risk Atlas · Inflammation
Inflammation is not just a response to injury. Around plaque, it can become part of the problem.
Inflammation around an artery plaque is a distinct biological process from the plaque buildup itself. It can make plaque more active, more unstable, and more likely to progress toward rupture. This module picks up where the Plaque atlas stops — with an existing plaque — and shows how inflammatory activity can change the artery environment around it. Use the slider to move from a stable artery through early inflammation, active plaque, higher instability, and a high-risk educational state. Then continue to the Rupture module to see what can follow.
hs-CRP
A measurable marker
High-sensitivity C-reactive protein is one of the most studied inflammatory markers in cardiovascular risk. Elevated hs-CRP can indicate heightened systemic inflammation — but it is a signal, not a diagnosis.
Lp(a)
Pro-inflammatory biology
Lp(a) carries oxidised phospholipids with pro-inflammatory properties. This is one reason elevated Lp(a) can affect plaque biology beyond simple lipid burden — it can amplify the inflammatory environment around a plaque.
Cap
Where it matters most
Inflammation is particularly significant at the fibrous cap — the cover over a plaque's lipid core. Inflammatory activity can thin and weaken the cap, which is why it connects directly to rupture risk in the next atlas module.
Why inflammation is separate from plaque
Plaque buildup and inflammatory activity are distinct processes. Plaque accumulates structural material; inflammation is a biological response that can change plaque behaviour. Both can be present at once, amplifying each other.
Why standard tests may not show it
A standard lipid panel does not measure inflammation. hs-CRP is a separate test. Lp(a)-associated inflammatory biology is separate again. Elevated Lp(a) can contribute to plaque-related inflammation even when hs-CRP is not elevated.
Why this connects to rupture
An inflamed plaque environment can weaken the fibrous cap that separates lipid material from flowing blood. A weakened cap under stress can crack or rupture — which is the focus of the next atlas module and the hand-off point from this one.
Five things worth knowing about inflammation and heart risk
- Inflammation is not the same as infection. In the cardiovascular context, it is a chronic, often silent biological state within and around artery walls — not a visible or acute response like a swollen joint.
- hs-CRP is a useful but non-specific marker. It can be elevated for many reasons. In cardiovascular risk assessment, it is most useful when interpreted alongside lipid markers, Lp(a), blood pressure, and family history.
- Lp(a) carries pro-inflammatory oxidised phospholipids. This is distinct from its atherogenic (plaque-building) role. A person with elevated Lp(a) may have heightened inflammatory activity around plaques even without an elevated hs-CRP.
- Statins have anti-inflammatory as well as lipid-lowering effects. This is one reason statins are discussed not only as LDL-C-lowering medicines but also as risk-reducing therapies with anti-inflammatory effects. The JUPITER trial is the common reference point for this conversation.
- Inflammation around a plaque is not visible on a standard blood test. Imaging, calcium scoring, and specialist assessment can add context that routine blood markers cannot. Ask your health team whether additional assessment is relevant to your situation.
Inflammation visualisation
Activity view makes inflammatory signals more prominent — highlighting the glow around the plaque environment, endothelial irritation, and immune-cell activity — so the biological context is easier to read alongside the stage explanation.
Stable artery with plaque
Key information
Inflammation: what to understand
It can change plaque behaviour
Inflammation can make a plaque environment more biologically active. That may matter for growth, cap stress, and downstream clot-related risk context.
The endothelium is active
The inner artery lining helps regulate vessel tone, clotting balance, and inflammatory signalling. It is not just a passive surface.
Many factors can add irritation
Blood pressure, smoking, metabolic risk, kidney disease, ApoB, and Lp(a) can all shape inflammatory context. The module deliberately avoids reducing inflammation to one trigger.
Markers are context, not proof
Blood markers such as hs-CRP can add context to a risk discussion. They do not by themselves prove that a specific plaque is inflamed or unstable.
Inflammation connects modules
Inflammation sits between plaque formation, rupture risk, clot formation, heart attack, and stroke. It helps explain why risk can be more than narrowing alone.
Inflammation is not the same as clot
Inflammatory activity and clot formation are related but separate processes. Mixing them together makes the pathway harder to understand.
High inflammation does not mean an event is inevitable
A higher inflammatory context is a reason to clarify risk, not a prediction. Prevention focuses on modifiable drivers and appropriate medical decisions.
This visual does not diagnose artery inflammation
The atlas explains a mechanism. It cannot tell whether inflammation is present in your arteries or how active it is.
Heart risk products
Inflammation is only one layer of the wider picture.
Cardiovascular inflammation adds to a risk context that can already include plaque burden, ApoB, elevated Lp(a), family history, blood pressure, and metabolic risk. If you want help understanding what your current checks do and do not show, Clarify is the right starting point — particularly if you have seen inflammatory or Lp(a) results you do not fully understand. If you already have results or signals to connect, Navigate gives you a structured 90-day framework. If you want to build lasting preventive action, Prevent is designed for ongoing follow-through.